AstraZeneca PLC (LON:0A4J)
67.00
+0.17 (0.25%)
At close: Apr 22, 2025
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 182.83 billion as of August 29, 2025. Its market cap has decreased by -9.60% in one year.
Market Cap
182.83B
Enterprise Value
201.75B
Revenue
41.24B
Ranking
n/a
PE Ratio
30.20
Stock Price
67.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 182.83B, an increase of 3,917.79%. That is a compound annual growth rate of 12.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 183.14B | 12.85% |
Dec 31, 2024 | 162.29B | -1.22% |
Dec 29, 2023 | 164.29B | -5.48% |
Dec 30, 2022 | 173.83B | 29.30% |
Dec 31, 2021 | 134.44B | 39.83% |
Dec 31, 2020 | 96.14B | -3.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 183.14B |
HSBC Holdings | 165.35B |
Shell | 158.86B |
Unilever | 114.85B |
British American Tobacco p.l.c. | 90.52B |
Rolls-Royce Holdings | 88.93B |
Rio Tinto Group | 78.83B |
BP p.l.c. | 66.36B |